Koyfin Home > Directory > Health Care > Revance Therapeutics > Altman Z-score

Revance Therapeutics Altman Z-score Chart (RVNC)

Revance Therapeutics annual/quarterly Altman Z-score from 2020 to 2020.
  • Revance Therapeutics Altman Z-score for the quarter ending June 06, 2020 was -0.60
  • Revance Therapeutics Altman Z-score for the last 12 months ending June 06, 2020 was -0.95
Other Balance Sheet Metrics:
  • Revance Therapeutics Total Assets for the quarter ending September 09, 2018 was $233m a -26.88% decrease of -63m year over year
  • Revance Therapeutics Other Liabilities for the quarter ending September 09, 2018 was $19m a 68.91% increase of 13m year over year
  • Revance Therapeutics Total Equity for the quarter ending September 09, 2018 was $182m a -47.64% decrease of -87m year over year
View Chart On Koyfin

Quarterly RVNC Altman Z-score Data

06/2020-0.60

Annual RVNC Altman Z-score Data

2019-0.84